Vimarsana
Biggest News Aggregation in the World

Page 16 - Brain Chip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain Chip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Chip Today - Breaking & Trending Today

Elon Musk's brain chip may help people control phones with thoughts, as USFDA clears human trials - Vimarsana News

Elon Musk's brain chip may help people control phones with thoughts, as USFDA clears human trials

The device enables people to operate computers and smartphones with their mind, without moving a finger or saying a word.

Would you get a brain implant? Neuralink says it will start human trials - National - Vimarsana News

Would you get a brain implant? Neuralink says it will start human trials - National

Elon Musk's implant research company Neuralink tweeted that it has received approval from the U.S. Food and Drug Administration to launch its 'first-in-human clinical study.'

Would you get a brain implant? Neuralink says it will start human trials - Vimarsana News

Would you get a brain implant? Neuralink says it will start human trials

Elon Musk’s implant research company Neuralink tweeted that it has received approval from the U.S. Food and Drug Administration to launch its ‘first-in-human clinical study.’

Source: q107.com
Brain chips implanted in people to cure fatal ailments; know new technique of biotech firm - Vimarsana News

Brain chips implanted in people to cure fatal ailments; know new technique of biotech firm

The firm aims to allow individuals with the implant to control robotic arms and electric wheelchairs using their thoughts.

Elon Musk fails to mention the FDA rejected his push for brain chip human trials - Vimarsana News

Elon Musk fails to mention the FDA rejected his push for brain chip human trials

Elon Musk has moved the goalposts for when human trials will begin for Neuralink at least four times since 2019, but it's yet to get regulatory approval.